51
Participants
Start Date
September 30, 2012
Primary Completion Date
April 30, 2016
Study Completion Date
September 19, 2016
Group 2a. Telemedicine program
CSII (Accu-Chek Spirit®) and medical monitoring via telematics application (Emminens Conecta® System, Roche Diagnostics SL) (TM) (6 months).
Group 1a. Control
Treatment with CSII (Accu-Chek Spirit®) and follow-face doctor visits (conventional treatment -SMC-) (6 months).
Group 1b.Telemedicine program
After a washout period of 3 months and the crossing, Group 1 begins with medical monitoring via telematics application (Emminens Conecta® System, Roche Diagnostics SL) (TM) (6 months).
Group 2b. Control
After a washout period of 3 months and the crossing, Group 2 begins with face doctor visits (conventional treatment -SMC-) (6 months) .
Ministerio de Economía y Competitividad, Spain
OTHER_GOV
Andaluz Health Service
OTHER_GOV
Roche Pharma AG
INDUSTRY
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
OTHER